Circulating endothelial cells are increased in chronic myeloid leukemia blast crisis

• Published in: Brazilian journal of medical and biological research Vol. 48; no. 6; pp. 509 - 514
• Main Authors: C.R.T. Godoy, D. Levy, V. Giampaoli, D.A.F. Chamone, S.P. Bydlowski, J. Pereira
• Format: Journal Article
• Language: English
• Published: Associação Brasileira de Divulgação Científica 01.03.2015
• Subjects: Angiogenesis; Chronic myeloid leukemia; Circulating endothelial cells; Flow cytometry; Vascular endothelial growth factor
• ISSN: 1414-431X
• DOI: 10.1590/1414-431x20153646

We measured circulating endothelial precursor cells (EPCs), activated circulating endothelial cells (aCECs), and mature circulating endothelial cells (mCECs) using four-color multiparametric flow cytometry in the peripheral blood of 84 chronic myeloid leukemia (CML) patients and 65 healthy controls; and vascular endothelial growth factor (VEGF) by quantitative real-time PCR in 50 CML patients and 32 healthy controls. Because of an increase in mCECs, the median percentage of CECs in CML blast crisis (0.0146%) was significantly higher than in healthy subjects (0.0059%, P<0.01) and in the accelerated phase (0.0059%, P=0.01). There were no significant differences in the percentages of CECs in chronic- or active-phase patients and healthy subjects (P>0.05). In addition, VEGF gene expression was significantly higher in all phases of CML: 0.245 in blast crisis, 0.320 in the active phase, and 0.330 in chronic phase patients than it was in healthy subjects (0.145). In conclusion, CML in blast crisis had increased levels of CECs and VEGF gene expression, which may serve as markers of disease progression and may become targets for the management of CML.